Adam Townsend

(Mr. Adam Townsend)

Currently holds a position at Apellis Pharmaceuticals Inc

Positions
Position Company Period
Chief Commercial Officer Apellis Pharmaceuticals Inc Nov. 20, 2018 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2024-02-13 2024-02-12
S Sale
1,148 -1.2%
67.77
77,796 USD
1,148 -1.2% 67.77 77,796 USD
2024-01-31 2024-01-29
S Sale
906 -1.0%
64.14
58,109 USD
906 -1.0% 64.14 58,109 USD
2024-01-23 2024-01-22
S Sale
3,413 -3.5%
65.00
221,831 USD
3,413 -3.5% 65.00 221,831 USD
2024-01-17 2024-01-16
S Sale
2,235 -2.2%
66.81
149,317 USD
2,235 -2.2% 66.81 149,317 USD
2023-05-04 2023-05-03
PS Planned sale
5,000 -6.2%
82.71
413,550 USD
5,000 -6.2% 82.71 413,550 USD
2023-03-07 2023-03-03
PS Planned sale
5,000 -6.2%
63.84
319,200 USD
5,000 -6.2% 63.84 319,200 USD
2023-02-06 2023-02-03
PS Planned sale
5,000 -6.9%
55.85
279,250 USD
5,000 -6.9% 55.85 279,250 USD
2023-01-05 2023-01-03
PS Planned sale
5,000 -10.4%
50.70
253,500 USD
5,000 -10.4% 50.70 253,500 USD
2022-12-07 2022-12-05
PS Planned sale
5,000 -10.4%
50.38
251,900 USD
5,000 -10.4% 50.38 251,900 USD
2022-11-07 2022-11-03
PS Planned sale
5,000 -10.4%
58.54
292,700 USD
5,000 -10.4% 58.54 292,700 USD
2022-09-07 2022-09-06
PS Planned sale
5,000 -10.4%
60.38
301,900 USD
5,000 -10.4% 60.38 301,900 USD
2022-08-16 2022-08-15
PS Planned sale
12,500 -22.6%
69.00
862,500 USD
12,500 -22.6% 69.00 862,500 USD
2022-08-12 2022-08-11
PS Planned sale
12,500 -22.6%
67.00
837,500 USD
12,500 -22.6% 67.00 837,500 USD
2022-08-09 2022-08-08
PS Planned sale
12,500 -22.6%
65.00
812,500 USD
12,500 -22.6% 65.00 812,500 USD
2022-08-04 2022-08-03
PS Planned sale
5,000 -11.7%
56.43
282,150 USD
5,000 -11.7% 56.43 282,150 USD